| |
| |
|
| Insider
Information: |
Carmine Bryce D. |
| Relationship: |
EVP and Pres, Lilly Bi... |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
51,186 |
|
|
Indirect Shares
|
6,869 |
|
|
| Direct
Value |
$41,329,112 |
|
|
|
Indirect Value
|
$5,546,237 |
|
|
| Total
Shares |
58,055 |
|
|
| Total
Value |
$46,875,349 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
EVP and Pres, Lilly Bi... |
2011-12-29 |
51,186 |
2011-12-29 |
6,869 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
EVP and Pres, Est Markets BU |
• – – |
2010-01-26 |
4 |
A |
$36.16 |
$149,160 |
D/D |
4,125 |
42,160 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-08-16 |
4 |
AS |
$35.33 |
$109,523 |
D/D |
(3,100) |
72,640 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-09-16 |
4 |
AS |
$35.55 |
$110,205 |
D/D |
(3,100) |
69,540 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-10-15 |
4 |
AS |
$37.65 |
$116,715 |
D/D |
(3,100) |
66,440 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-11-16 |
4 |
AS |
$34.43 |
$106,733 |
D/D |
(3,100) |
63,340 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-12-16 |
4 |
AS |
$35.10 |
$108,810 |
D/D |
(3,100) |
60,030 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-01-14 |
4 |
AS |
$34.87 |
$108,097 |
D/D |
(3,100) |
56,930 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-02-16 |
4 |
AS |
$34.49 |
$106,919 |
D/D |
(3,100) |
103,407 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-04-11 |
4 |
AS |
$35.76 |
$203,832 |
D/D |
(5,700) |
97,707 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-05-11 |
4 |
AS |
$38.21 |
$217,797 |
D/D |
(5,700) |
92,007 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-06-13 |
4 |
AS |
$37.25 |
$212,325 |
D/D |
(5,700) |
86,307 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-07-11 |
4 |
AS |
$37.39 |
$213,123 |
D/D |
(5,700) |
79,998 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-08-11 |
4 |
AS |
$33.94 |
$193,458 |
D/D |
(5,700) |
74,298 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-09-12 |
4 |
AS |
$35.91 |
$204,687 |
D/D |
(5,700) |
68,453 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-10-11 |
4 |
AS |
$38.10 |
$217,170 |
D/D |
(5,700) |
62,753 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-11-11 |
4 |
AS |
$37.55 |
$214,035 |
D/D |
(5,700) |
57,053 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-12-12 |
4 |
AS |
$39.10 |
$226,272 |
D/D |
(5,787) |
51,266 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Est Markets BU |
• – – |
2010-02-01 |
4 |
D |
$35.20 |
$621,949 |
D/D |
(17,669) |
75,740 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2011-02-01 |
4 |
D |
$34.77 |
$1,097,167 |
D/D |
(31,555) |
106,507 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP, Global Marketing & Sales |
• – – |
2008-06-17 |
5 |
GD |
$0.00 |
$0 |
D/D |
312 |
39,916 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP, Global Marketing & Sales |
• – – |
2008-12-08 |
5 |
GD |
$0.00 |
$0 |
D/D |
285 |
39,631 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Est Markets BU |
• – – |
2009-03-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
630 |
38,909 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Est Markets BU |
• – – |
2009-06-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
630 |
38,279 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Est Markets BU |
• – – |
2009-12-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
244 |
38,035 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP and Pres, Lilly Bio-Meds |
• – – |
2010-03-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
330 |
75,410 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
